Breast Cancer Seen as Model for Precision Medicine, Care Decisions

By Elizabeth Gardner

Chicago—Although there is continued debate about how much precision approaches can influence cancer care—with early reports from the NCI-MATCH (National Cancer Institute-Molecular Analysis for Therapy Choice) trial showing limited application of genomic results despite a focused initiative (Table)—breast cancer can provide a template for how precision medicine can be applied to improve patient management, according to Steven Katz, MD, the director of the